Mouse Anti-LIX1L Recombinant Antibody (CBYJL-1793) (CBMAB-L1731-YJ)

Moore, K. S., Moore, R., Fulmer, D. B., Guo, L., Gensemer, C., Stairley, R., ... & Norris, R. A. (2022). DCHS1, Lix1L, and the septin cytoskeleton: molecular and developmental etiology of mitral valve prolapse. Journal of Cardiovascular Development and Disease, 9(2), 62.

Li, M., Zhang, J., Meng, X., Liu, B., Xie, S., Liu, F., ... & Xing, L. (2022). LIX1L promotes EMT and EGFR-TKIs resistance via nucleolin-mediated ribosomal RNA synthesis in NSCLC.

Li, J., Zhu, X., Zhang, M., Zhang, Y., Ye, S., Leng, Y., ... & Zhang, H. (2021). Limb expression 1-like (LIX1L) protein promotes cholestatic liver injury by regulating bile acid metabolism. Journal of hepatology, 75(2), 400-413.

Zhu, X., Zhang, Y., Zhao, Y., Xiang, D., Zou, J., Andrisani, O., ... & Kong, L. (2021). LIX1-like protein drives hepatic stellate cell activation to promote liver fibrosis by regulation of chemokine mRNA stability. Signal Transduction and Targeted Therapy, 6(1), 319.

Zou, J., Zhu, X., Xiang, D., Zhang, Y., Li, J., Su, Z., ... & Zhang, H. (2021). LIX1-like protein promotes liver cancer progression via miR-21-3p-mediated inhibition of fructose-1, 6-bisphosphatase. Acta Pharmaceutica Sinica B, 11(6), 1578-1591.

Jie, Z. O. U., Xiaoyun, Z. H. U., XIANG, D., ZHANG, Y., Jie, L. I., Zhigui, S. U., ... & ZHANG, H. (2021). LIX1-like protein promotes liver cancer progression. Acta Pharmaceutica Sinica B, 1578-1591.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols

Isotype control